×
返回 Agenda
TOPIC 5 SESSION 5: Effectiveness of Risk Minimisation Measures
Session Chair(s)
Gaby L. Danan, MD, PHD
Pharmacovigilance Expert
GLD, France
Phil Tregunno
Deputy Director - Patient Safety Monitoring
Medicines and Healthcare Products Regulatory Agency (MHRA), United Kingdom
Speaker(s)
Effectiveness of Risk Minimisation Measures
Jan Petracek, MD, MSC
iVigee Services a.s., Czech Republic
CEO